Neogenomics, Inc. last reported quarterly results on Oct 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $209.3 million (+11.4% year over year). It usually reports 5–28 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 11, 2027.
Results for Q4 FY2026, the quarter ending around Dec 31, 2026. Expected on a Monday. Based on last year's release for the same quarter on Jan 12, 2026. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 5–28 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Oct 5, 2026
5 days after quarter end
|
Q3 FY2026
ended Sep 30, 2026
|
209
+11.4%
|
-8
+72.2%
|
—
|
|
Jul 28, 2026
28 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
202
+11.2%
|
2
+105.0%
|
—
|
|
Apr 28, 2026
28 days after quarter end
|
Q1 FY2026
ended Mar 31, 2026
|
187
+11.1%
|
-17
+34.0%
|
—
|
|
Jan 12, 2026
12 days after quarter end
|
Q4 FY2025
ended Dec 31, 2025
|
190
+10.6%
|
-10
+35.5%
|
—
|
|
Oct 28, 2025
28 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
188
+11.9%
|
-27
-53.3%
|
—
|
|
Jul 29, 2025
29 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
181
+10.2%
|
-45
-141.9%
|
—
|
|
Apr 29, 2025
29 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
168
+7.5%
|
-26
+4.2%
|
—
|
|
Feb 18, 2025
49 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
172
+10.6%
|
-15
-7.0%
|
—
|
Company profile
- Industry
- Services-Testing Laboratories (SIC 8734)
- Listed as
- NEO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Fort Myers, FL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1077183
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC (until Feb 5, 2002)
Other Services-Testing Laboratories companies
- UL Solutions Inc. ULS
- 20/20 Biolabs, Inc. AIDX
- Hypha Labs, Inc. FUNI
Source: SEC EDGAR filings. This is company-reported data, not investment advice.